American International Group Inc vs Novo Nordisk A/S — how do they compare? American International Group Inc trades at $77.14 (market cap $40.42B), while Novo Nordisk A/S trades at $46.02 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 5.1× American International Group Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| AIG | NVO | |
|---|---|---|
Market Cap | $40.42B | $207.85B |
Sector | Financials | Health |
52-Week High | $86.59 | $63.98 |
52-Week Low | $71.89 | $35.29 |
Enterprise Value | $48.06B | $222.55B |
Dividend Yield | 2.59% | 3.81% |
Trailing returns across standard periods
Latest headlines on both assets
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. Its revenue is split roughly evenly between commercial and consumer lines.
Read more on AIG →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →